| Assessment Status | Rapid Review complete |
| HTA ID | - |
| Drug | Bazedoxifene |
| Brand | Conbriza® |
| Indication | Treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of verterbral fractures has been demonstrated; efficacy on hip fractures has not been established. |
| Assessment Process | |
| Rapid review commissioned | 20/09/2011 |
| Rapid review completed | 02/11/2011 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended. |